erythrosine has been researched along with Cystic Fibrosis in 22 studies
Fluoresceins: A family of spiro(isobenzofuran-1(3H),9'-(9H)xanthen)-3-one derivatives. These are used as dyes, as indicators for various metals, and as fluorescent labels in immunoassays.
Cystic Fibrosis: An autosomal recessive genetic disease of the EXOCRINE GLANDS. It is caused by mutations in the gene encoding the CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR expressed in several organs including the LUNG, the PANCREAS, the BILIARY SYSTEM, and the SWEAT GLANDS. Cystic fibrosis is characterized by epithelial secretory dysfunction associated with ductal obstruction resulting in AIRWAY OBSTRUCTION; chronic RESPIRATORY INFECTIONS; PANCREATIC INSUFFICIENCY; maldigestion; salt depletion; and HEAT PROSTRATION.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The fluorescein dilaurate test, a non-invasive test of exocrine pancreatic function, was carried out on 21 children with cystic fibrosis and pancreatic exocrine insufficiency, and 12 healthy siblings." | 7.68 | Fluorescein dilaurate test of exocrine pancreatic function in cystic fibrosis. ( Dalzell, AM; Heaf, DP, 1990) |
| "As a simple non-invasive test of possible pancreatic insufficiency 10 healthy infants, 13 infants with cystic fibrosis, and nine infants with unexplained diarrhoea and failure to thrive were given an emulsion containing fluorescein dilaurate and mannitol by mouth." | 3.69 | Spot urine pancreolauryl test for use in infancy. ( Austin, S; Green, MR; Jolliffe, S; McClean, P; Weaver, LT, 1995) |
| "The fluorescein dilaurate test, a non-invasive test of exocrine pancreatic function, was carried out on 21 children with cystic fibrosis and pancreatic exocrine insufficiency, and 12 healthy siblings." | 3.68 | Fluorescein dilaurate test of exocrine pancreatic function in cystic fibrosis. ( Dalzell, AM; Heaf, DP, 1990) |
| "When fluorescein dilaurate and mannitol were taken together and the results expressed as ratios of percentage fluorescein to percentage mannitol recovery (F:M ratio) (mean (SD)) there was clear discrimination between healthy subjects and those with cystic fibrosis regardless of enzyme replacement treatment (57." | 1.29 | Dual marker one day pancreolauryl test. ( Austin, S; Green, MR; Weaver, LT, 1993) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 7 (31.82) | 18.7374 |
| 1990's | 7 (31.82) | 18.2507 |
| 2000's | 2 (9.09) | 29.6817 |
| 2010's | 6 (27.27) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bronckers, AL | 1 |
| Lyaruu, DM | 1 |
| Guo, J | 1 |
| Bijvelds, MJ | 1 |
| Bervoets, TJ | 1 |
| Zandieh-Doulabi, B | 1 |
| Medina, JF | 1 |
| Li, Z | 1 |
| Zhang, Y | 1 |
| DenBesten, PK | 1 |
| Kolpen, M | 1 |
| Appeldorff, CF | 1 |
| Brandt, S | 1 |
| Mousavi, N | 1 |
| Kragh, KN | 1 |
| Aydogan, S | 1 |
| Uppal, HA | 1 |
| Bjarnsholt, T | 1 |
| Ciofu, O | 1 |
| Høiby, N | 1 |
| Jensen, PØ | 1 |
| Schmid, A | 1 |
| Sutto, Z | 1 |
| Schmid, N | 1 |
| Novak, L | 1 |
| Ivonnet, P | 1 |
| Horvath, G | 1 |
| Conner, G | 1 |
| Fregien, N | 1 |
| Salathe, M | 1 |
| Forier, K | 1 |
| Messiaen, AS | 1 |
| Coenye, T | 1 |
| Nelis, H | 1 |
| Celen, S | 1 |
| Van Calenbergh, S | 1 |
| De Smedt, S | 1 |
| Demeester, J | 1 |
| Braeckmans, K | 1 |
| Nam, SW | 1 |
| Chen, X | 1 |
| Lim, J | 1 |
| Kim, SH | 1 |
| Kim, ST | 1 |
| Cho, YH | 1 |
| Yoon, J | 1 |
| Park, S | 1 |
| Dunlevy, FK | 1 |
| Martin, SL | 1 |
| de Courcey, F | 1 |
| Elborn, JS | 1 |
| Ennis, M | 1 |
| Paradiso, AM | 1 |
| Coakley, RD | 1 |
| Boucher, RC | 1 |
| Jacobs, LR | 1 |
| De Fontes, D | 1 |
| Cox, KL | 1 |
| Schönberger, W | 1 |
| Weitzel, D | 1 |
| Green, MR | 2 |
| Austin, S | 2 |
| McClean, P | 1 |
| Jolliffe, S | 1 |
| Weaver, LT | 2 |
| Whitcombe, D | 1 |
| Brownie, J | 1 |
| Gillard, HL | 1 |
| McKechnie, D | 1 |
| Theaker, J | 1 |
| Newton, CR | 1 |
| Little, S | 1 |
| Frühwirth, M | 1 |
| Ruedl, C | 1 |
| Ellemunter, H | 1 |
| Böck, G | 1 |
| Wolf, H | 1 |
| Jayaraman, S | 1 |
| Song, Y | 1 |
| Vetrivel, L | 1 |
| Shankar, L | 1 |
| Verkman, AS | 1 |
| Chehab, FF | 1 |
| Wall, J | 1 |
| Kan, YW | 1 |
| Forsyth, JS | 2 |
| Dalzell, AM | 1 |
| Heaf, DP | 1 |
| Cumming, JG | 1 |
| Boyd, EJ | 1 |
| Frost, GJ | 1 |
| Cuschieri, A | 1 |
| Puntis, J | 1 |
| Botelho, SY | 1 |
| Goldstein, AM | 1 |
| Rosenlund, ML | 1 |
| Lev, R | 1 |
| Stoward, PJ | 1 |
| Ores, CN | 1 |
| Baker, DC | 1 |
1 trial available for erythrosine and Cystic Fibrosis
| Article | Year |
|---|---|
Flow-cytometric evaluation of oxidative burst in phagocytic cells of children with cystic fibrosis.
Topics: Adolescent; Adult; Antigen-Antibody Complex; C-Reactive Protein; Child; Child, Preschool; Cystic Fib | 1998 |
21 other studies available for erythrosine and Cystic Fibrosis
| Article | Year |
|---|---|
Composition of mineralizing incisor enamel in cystic fibrosis transmembrane conductance regulator-deficient mice.
Topics: Ameloblasts; Amelogenesis; Animals; Bicarbonates; Buffers; Calcium; Cariostatic Agents; Chlorides; C | 2015 |
Increased bactericidal activity of colistin on Pseudomonas aeruginosa biofilms in anaerobic conditions.
Topics: Aerobiosis; Anaerobiosis; Anti-Bacterial Agents; Biofilms; Colistin; Colony Count, Microbial; Cystic | 2016 |
Decreased soluble adenylyl cyclase activity in cystic fibrosis is related to defective apical bicarbonate exchange and affects ciliary beat frequency regulation.
Topics: Adenylyl Cyclase Inhibitors; Adenylyl Cyclases; Bicarbonates; Cilia; Cyclic AMP; Cystic Fibrosis; Cy | 2010 |
Transport and delivery of antimicrobial agents in Burkholderia biofilms.
Topics: Anti-Infective Agents; Biofilms; Burkholderia; Cystic Fibrosis; Fluoresceins; Humans; Liposomes | 2010 |
In vivo fluorescence imaging of bacteriogenic cyanide in the lungs of live mice infected with cystic fibrosis pathogens.
Topics: Animals; Bacterial Load; Burkholderia cepacia complex; Cyanides; Cystic Fibrosis; Fluoresceins; Fluo | 2011 |
Anti-inflammatory effects of DX-890, a human neutrophil elastase inhibitor.
Topics: Anti-Inflammatory Agents; Cell Movement; Cells, Cultured; Cystic Fibrosis; Fluoresceins; Humans; In | 2012 |
Polarized distribution of HCO3- transport in human normal and cystic fibrosis nasal epithelia.
Topics: 4,4'-Diisothiocyanostilbene-2,2'-Disulfonic Acid; Adult; Amiloride; Barium; Bicarbonates; Biological | 2003 |
Cytochemical localization of small intestinal glycoconjugates by lectin histochemistry in controls and subjects with cystic fibrosis.
Topics: Biopsy; Child; Child, Preschool; Cystic Fibrosis; Female; Fluorescein-5-isothiocyanate; Fluoresceins | 1983 |
[Diagnosis of pancreatic insufficiency with fluorescein dilaurate in patients with cystic fibrosis (author's transl)].
Topics: Adolescent; Child; Cystic Fibrosis; Fluoresceins; Humans; Methods; Pancreatic Function Tests; Refere | 1980 |
Spot urine pancreolauryl test for use in infancy.
Topics: Cystic Fibrosis; Diarrhea; Exocrine Pancreatic Insufficiency; Failure to Thrive; Female; Fluorescein | 1995 |
Dual marker one day pancreolauryl test.
Topics: Administration, Oral; Adolescent; Adult; Biomarkers; Child; Cystic Fibrosis; Female; Fluorescein; Fl | 1993 |
A homogeneous fluorescence assay for PCR amplicons: its application to real-time, single-tube genotyping.
Topics: Alleles; BRCA2 Protein; Breast Neoplasms; Cystic Fibrosis; DNA; DNA, Neoplasm; Factor V; Female; Flu | 1998 |
Noninvasive in vivo fluorescence measurement of airway-surface liquid depth, salt concentration, and pH.
Topics: Animals; Bronchoscopy; Cattle; Cells, Cultured; Cystic Fibrosis; Fiber Optic Technology; Fluorescein | 2001 |
Amplification and detection of specific DNA sequences with fluorescent PCR primers: application to delta F508 mutation in cystic fibrosis.
Topics: Alleles; Base Sequence; Cystic Fibrosis; DNA; DNA, Recombinant; Electrophoresis, Polyacrylamide Gel; | 1992 |
Fluorescein dilaurate test of exocrine pancreatic function in cystic fibrosis.
Topics: Cystic Fibrosis; Fluoresceins; Humans; Indicators and Reagents; Pancreatic Function Tests | 1991 |
Fluorescein dilaurate test of exocrine pancreatic function in cystic fibrosis.
Topics: Adolescent; Child; Child, Preschool; Cystic Fibrosis; Exocrine Pancreatic Insufficiency; Female; Flu | 1990 |
Diagnosis of exocrine pancreatic insufficiency in cystic fibrosis by use of fluorescein dilaurate test.
Topics: Adolescent; Adult; Child; Child, Preschool; Chymotrypsin; Cystic Fibrosis; Exocrine Pancreatic Insuf | 1986 |
Diagnosis of exocrine pancreatic insufficiency in cystic fibrosis by use of fluorescein dilaurate test.
Topics: Cystic Fibrosis; Exocrine Pancreatic Insufficiency; Fluoresceins; Humans; Pancreatic Function Tests | 1986 |
Tear sodium, potassium, chloride, and calcium at various flow rates: children with cystic fibrosis and unaffected siblings with and without corneal staining.
Topics: Calcium; Child; Chlorides; Cornea; Cystic Fibrosis; Eye; Fluoresceins; Humans; Potassium; Sodium; St | 1973 |
On the use of eosin as a fluorescent dye to demonstrate mucous cells and other structures in tissue sections.
Topics: Animals; Colitis, Ulcerative; Cystic Fibrosis; Dogs; Duodenum; Exocrine Glands; Fluoresceins; Gastri | 1969 |
Localization of hemoptysis in patients with cystic fibrosis.
Topics: Adult; Bronchiectasis; Bronchoscopes; Cystic Fibrosis; Fluoresceins; Hemoptysis; Humans; Male; Metho | 1969 |